Back to the main directory
EarningsReview / Equity
- Ringkjøbing Landbobank - Cost efficiency and credit quality key vs COVID-19 by Danske Bank Equity Research
- Q120 postview (+15 questions for management) by BNP Paribas
- Shifting to home advantage but with b/s pressure by BNP Paribas
- Santander CIB: Aena: 1Q20: Agrees to Re-negotiate MAGRs by Santander
- Micro Systemation - Q1 largely unaffected – now waiting for orders to come by Danske Bank Equity Research
- IAR Systems To show durability during downturn by DnB Markets
- Metsä Board - H1 outlook surprises positively, valuation unattractive by Danske Bank Equity Research
- Nordea - Nordea Q1 supports our Buy case by Danske Bank Equity Research
- Konecranes - Recovery more important than the weak 2020 by Danske Bank Equity Research
- Assa Abloy - BUY ahead of H2 upturn by Danske Bank Equity Research
- Swedish Orphan Biovitrum - Lock and load by Danske Bank Equity Research
- Bank Of China Ltd (3988 HK/601988 CH) by HSBC
- SEB - A weak quarter pointing to real strength by Danske Bank Equity Research
- Wallenstam (Sell, TP: SEK90.00) - Funding cost on the rise by DnB Markets
- Coor Service Management (Buy, TP: SEK72.00) - Well-adjusted in Q1 by DnB Markets
- TietoEVRY (Buy, TP: EUR28.00) - Q1 a mixed bag, but it’s time to BUY into the story by DnB Markets
- Scandic Hotels (No_rec, TP: SEK) - Recommendation withdrawn by DnB Markets
- Transocean (Sell, TP: USD0.50) - Dinosaur risk by DnB Markets
- Wallenstam (Sell, TP: SEK90.00) - Funding cost on the rise by DnB Markets
- SEB (Buy, TP: SEK108.00) - by DnB Markets
- Novozymes (Sell, TP: DKK290.00) - Not the time to turn optimistic by DnB Markets
- Norsk Hydro (Buy, TP: NOK32.00) - Improving cost position by DnB Markets
- Konecranes (Buy, TP: EUR25.00) - On the weaker side by DnB Markets
- Borregaard (Hold, TP: NOK100.00) - Holding up well despite headwinds by DnB Markets
- Tokmanni - Bargain hunting as a trend will stay by Danske Bank Equity Research
- Updating estimates for COVID19 and Q1 20 preview by BNP Paribas
- Unilever Indonesia (UNVR IJ) by HSBC
- Strong Q1 results, boosted by Covid-19 by BNP Paribas
- Safe balance sheet but limited room to absorb losses by BNP Paribas
- XXL - Still in defensive mode, priced expensively by Danske Bank Equity Research
- Not what we''re used to by BNP Paribas
- Q1: Keeping its head above water by BNP Paribas
- Ørsted - Solid performance in difficult markets by Danske Bank Equity Research
- Sinch - Q1 20 beat inflated some by COVID-19 effects by Danske Bank Equity Research
- Q1 20 results as expected, resilience to Covid-19 by BNP Paribas
- Xinjiang Goldwind (2208 HK/002202 CH) by HSBC
- Sydbank - Only when the tide goes out by Danske Bank Equity Research
- Novozymes (Sell, TP: DKK290.00) - No surprises by DnB Markets
- Royal Unibrew (Buy, TP: DKK580.00) - Q1 has not changed much by DnB Markets
- Wihlborgs (Buy, TP: SEK158.00) - NAV growth driven by FX by DnB Markets
- Polarcus (Sell, TP: NOK0.10) - Need to address capital structure by DnB Markets
- Subsea 7 (Buy, TP: NOK70.00) - Watch out for project delays by DnB Markets
- Pandox (Buy, TP: SEK170.00) - Light at the end of the tunnel by DnB Markets
- SEB (Buy, TP: SEK108.00) - by DnB Markets
- SEB (Buy, TP: SEK108.00) - by DnB Markets
- SEB (Buy, TP: SEK108.00) - Quality still not reflected in pricing by DnB Markets
- Konecranes (Buy, TP: EUR25.00) - On the weaker side by DnB Markets
- GN Group (Buy, TP: DKK350.00) - GN Audio in a sweet spot by DnB Markets
- GN Group (Buy, TP: DKK340.00) - by DnB Markets
- Lotte Chemical Titan (TTNP MK) by HSBC